Development of artificial intelligence for diagnosis and treatment of lung cancer

Development of artificial intelligence for diagnosis and treatment of lung cancer - Development of artificial intelligence for diagnosis and treatment of lung cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051034

Enrollment

600

Registered

2023-05-11

Start date

2023-05-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Aged 18 years or older (2)Patients who undergo HRCT imaging to diagnose a thoracic tumor and who will undergo at any least of the following: biopsy or surgery or post-operative pathology

Exclusion criteria

Exclusion criteria: Patients who did not provide consent to participate in the study

Design outcomes

Primary

Measure	Time frame
Accuracy in distinguishing benign and malignant pulmonary tumors utilizing artificial intelligence	—

Secondary

Measure	Time frame
Accuracy of the proportion of pathological invasion factors with artificial intelligence Reproducibility and objectivity of image parameters during 3D image analysis with artificial intelligence	—

Countries

Japan

Contacts

Public ContactYujin Kudo

Tokyo Medical University Hospital Department of Surgery

ykudo@tokyo-med.ac.jp03-3342-6111

Outcome results